Evidence map›Paper›PMID 27095876›Full record

ArticlePaediatrics & child health2016

Time to reconsider routine high-dose amoxicillin for community-acquired pneumonia in all Canadian children.

Nipunie Srimalie Rajapakse, Joseph Varkey Vayalumkal, Otto Gerben Vanderkooi, Leah Jeanne Ricketson, James Duncan Kellner

Abstract read
In one paragraph

Article in Paediatrics & child health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nipunie Srimalie RajapakseSection of Infectious Diseases, Department of Pediatrics, University of Calgary and Calgary Zone, Alberta Health Services;; Alberta Children's Hospital Research Institute (ACHRI);
Joseph Varkey VayalumkalSection of Infectious Diseases, Department of Pediatrics, University of Calgary and Calgary Zone, Alberta Health Services;; Alberta Children's Hospital Research Institute (ACHRI);
Otto Gerben VanderkooiSection of Infectious Diseases, Department of Pediatrics, University of Calgary and Calgary Zone, Alberta Health Services;; Alberta Children's Hospital Research Institute (ACHRI);; Calgary Streptococcus Pneumoniae Epidemiology Research Group (CASPER), Calgary, Alberta.
Leah Jeanne RicketsonCalgary Streptococcus Pneumoniae Epidemiology Research Group (CASPER), Calgary, Alberta.
James Duncan KellnerSection of Infectious Diseases, Department of Pediatrics, University of Calgary and Calgary Zone, Alberta Health Services;; Alberta Children's Hospital Research Institute (ACHRI);; Calgary Streptococcus Pneumoniae Epidemiology Research Group (CASPER), Calgary, Alberta.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27095876
PMCPMC4807794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.